Revlimid 2.5 MG Oral Capsule
- RxCUI
- 1242233
- RxNorm name
- Revlimid 2.5 MG Oral Capsule
- Display name
- Revlimid 2.5 MG Oral Capsule
- Full name
- Revlimid 2.5 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Revlimid | LENALIDOMIDE | Celgene Corporation | 5fa97bf5-28a2-48f1-8955-f56012d296be | 2023-03-24 | Boxed warning, Warnings, Adverse reactions | 1242233 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5fa97bf5-28a2-48f1-8955-f56012d296be | Revlimid 2.5 MG Oral Capsule | PSN | 40 | These highlights do not include all the information needed to use REVLIMID ® safely and effectively. See full prescribing information for REVLIMID. REVLIMID (lenalidomide) capsules, for oral use Initial U.S. Approval: 2005 | 20230324 |
| 5fa97bf5-28a2-48f1-8955-f56012d296be | Revlimid 2.5 MG Oral Capsule | SY | 40 | These highlights do not include all the information needed to use REVLIMID ® safely and effectively. See full prescribing information for REVLIMID. REVLIMID (lenalidomide) capsules, for oral use Initial U.S. Approval: 2005 | 20230324 |
| 5fa97bf5-28a2-48f1-8955-f56012d296be | lenalidomide 2.5 MG Oral Capsule [Revlimid] | SBD | 40 | These highlights do not include all the information needed to use REVLIMID ® safely and effectively. See full prescribing information for REVLIMID. REVLIMID (lenalidomide) capsules, for oral use Initial U.S. Approval: 2005 | 20230324 |